A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Trial details
- Registry ID
- NCT03588975
- Phase
- Phase 3
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeNCT03588975 | Vericel Corporation | Phase 3 | Recruiting | 2030-02Estimated |
| A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the AnkleNCT06915233 | Vericel Corporation | Phase 3 | Recruiting | 2030-07Estimated |
NCT03588975 · Vericel Corporation
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Measure: Proportion of Patients Who Achieve at Least a 10-point Improvement From Baseline in KOOS-Child Pain and Function (Sports and Recreational Activities) Scores
Measure: Proportion of Participants Who Achieve ≥ 10-point Improvement From Baseline in KOOS-Child Pain and Function (Sports and Recreational Activities) Subscale Scores
Jun 2027
Feb 2030
NCT06915233 · Vericel Corporation
Apr 2030
Jul 2030
Not yet recruiting
Recruiting